Frontlight ResearchEarly access
Trial site
Mannheim
- 4running trials
- 12closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia4 trials
- Multiple sclerosis4 trials
- Coronary artery disease3 trials
- Familial hypercholesterolaemia2 trials
- Stroke2 trials
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Myeloproliferative neoplasms1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed9 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Terminated2 trials
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals16 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Completed
Completed
Terminated
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 13 Nov 2026